Matches in Wikidata for { <http://www.wikidata.org/entity/Q34649050> ?p ?o ?g. }
- Q34649050 description "2013 nî lūn-bûn" @default.
- Q34649050 description "2013 թուականի Մարտին հրատարակուած գիտական յօդուած" @default.
- Q34649050 description "2013 թվականի մարտին հրատարակված գիտական հոդված" @default.
- Q34649050 description "2013年の論文" @default.
- Q34649050 description "2013年学术文章" @default.
- Q34649050 description "2013年学术文章" @default.
- Q34649050 description "2013年学术文章" @default.
- Q34649050 description "2013年学术文章" @default.
- Q34649050 description "2013年学术文章" @default.
- Q34649050 description "2013年學術文章" @default.
- Q34649050 description "2013年學術文章" @default.
- Q34649050 description "2013年學術文章" @default.
- Q34649050 description "2013年學術文章" @default.
- Q34649050 description "2013年學術文章" @default.
- Q34649050 description "2013年學術文章" @default.
- Q34649050 description "2013년 논문" @default.
- Q34649050 description "article científic" @default.
- Q34649050 description "article scientific" @default.
- Q34649050 description "article scientifique (publié 2013)" @default.
- Q34649050 description "articol științific" @default.
- Q34649050 description "articolo scientifico" @default.
- Q34649050 description "artigo científico (publicado na 2013)" @default.
- Q34649050 description "artigo científico (publicado na 2013)" @default.
- Q34649050 description "artigo científico" @default.
- Q34649050 description "artikull shkencor" @default.
- Q34649050 description "artikulong pang-agham" @default.
- Q34649050 description "artykuł naukowy" @default.
- Q34649050 description "artículo científico publicado en 2013" @default.
- Q34649050 description "artículu científicu espublizáu en 2013" @default.
- Q34649050 description "bilimsel makale" @default.
- Q34649050 description "bài báo khoa học" @default.
- Q34649050 description "mokslinis straipsnis" @default.
- Q34649050 description "naučni članak" @default.
- Q34649050 description "scienca artikolo" @default.
- Q34649050 description "scientific article" @default.
- Q34649050 description "teaduslik artikkel" @default.
- Q34649050 description "tieteellinen artikkeli" @default.
- Q34649050 description "tudományos cikk" @default.
- Q34649050 description "vedecký článok" @default.
- Q34649050 description "vetenskaplig artikel" @default.
- Q34649050 description "videnskabelig artikel (udgivet 2013)" @default.
- Q34649050 description "vitenskapelig artikkel" @default.
- Q34649050 description "vitskapeleg artikkel" @default.
- Q34649050 description "vědecký článek" @default.
- Q34649050 description "wetenschappelijk artikel" @default.
- Q34649050 description "wissenschaftlicher Artikel" @default.
- Q34649050 description "επιστημονικό άρθρο" @default.
- Q34649050 description "мақолаи илмӣ" @default.
- Q34649050 description "мақолаи илмӣ" @default.
- Q34649050 description "наукова стаття, опублікована в березні 2013" @default.
- Q34649050 description "научна статия" @default.
- Q34649050 description "научная статья" @default.
- Q34649050 description "научни чланак" @default.
- Q34649050 description "научни чланак" @default.
- Q34649050 description "מאמר מדעי" @default.
- Q34649050 description "سائنسی مضمون" @default.
- Q34649050 description "مقالة علمية نشرت بتاريخ 4-3-2013" @default.
- Q34649050 description "مقالهٔ علمی" @default.
- Q34649050 description "২০১৩-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ" @default.
- Q34649050 description "บทความทางวิทยาศาสตร์" @default.
- Q34649050 description "სამეცნიერო სტატია" @default.
- Q34649050 name "Capecitabine/irinotecan or capecitabine/oxaliplatin in combination with bevacizumab is effective and safe as first-line therapy for metastatic colorectal cancer: a randomized phase II study of the AIO colorectal study group." @default.
- Q34649050 name "Capecitabine/irinotecan or capecitabine/oxaliplatin in combination with bevacizumab is effective and safe as first-line therapy for metastatic colorectal cancer: a randomized phase II study of the AIO colorectal study group." @default.
- Q34649050 name "Capecitabine/irinotecan or capecitabine/oxaliplatin in combination with bevacizumab is effective and safe as first-line therapy for metastatic colorectal cancer: a randomized phase II study of the AIO colorectal study group." @default.
- Q34649050 type Item @default.
- Q34649050 label "Capecitabine/irinotecan or capecitabine/oxaliplatin in combination with bevacizumab is effective and safe as first-line therapy for metastatic colorectal cancer: a randomized phase II study of the AIO colorectal study group." @default.
- Q34649050 label "Capecitabine/irinotecan or capecitabine/oxaliplatin in combination with bevacizumab is effective and safe as first-line therapy for metastatic colorectal cancer: a randomized phase II study of the AIO colorectal study group." @default.
- Q34649050 label "Capecitabine/irinotecan or capecitabine/oxaliplatin in combination with bevacizumab is effective and safe as first-line therapy for metastatic colorectal cancer: a randomized phase II study of the AIO colorectal study group." @default.
- Q34649050 prefLabel "Capecitabine/irinotecan or capecitabine/oxaliplatin in combination with bevacizumab is effective and safe as first-line therapy for metastatic colorectal cancer: a randomized phase II study of the AIO colorectal study group." @default.
- Q34649050 prefLabel "Capecitabine/irinotecan or capecitabine/oxaliplatin in combination with bevacizumab is effective and safe as first-line therapy for metastatic colorectal cancer: a randomized phase II study of the AIO colorectal study group." @default.
- Q34649050 prefLabel "Capecitabine/irinotecan or capecitabine/oxaliplatin in combination with bevacizumab is effective and safe as first-line therapy for metastatic colorectal cancer: a randomized phase II study of the AIO colorectal study group." @default.
- Q34649050 P1433 Q34649050-95C4DB17-1625-4921-87AD-04B0E98E93E6 @default.
- Q34649050 P1476 Q34649050-E43200E9-DB41-4A7D-A521-79D78761D146 @default.
- Q34649050 P2093 Q34649050-0349321F-324E-4D51-B270-00C74B1F43F4 @default.
- Q34649050 P2093 Q34649050-08CAC9F7-2D27-4E4B-A9DF-6EF82846684D @default.
- Q34649050 P2093 Q34649050-091A7A06-6622-4A84-9538-2A8B32B6D053 @default.
- Q34649050 P2093 Q34649050-112D60C2-58E9-458B-8E1F-8E7C87F7146E @default.
- Q34649050 P2093 Q34649050-2246B9EC-1863-4717-B547-B3D7C1D152C7 @default.
- Q34649050 P2093 Q34649050-2D65DBDC-9A14-4B71-B853-AEF6AF72BADF @default.
- Q34649050 P2093 Q34649050-2E00A069-3E82-4033-BF32-416EACBE5CE3 @default.
- Q34649050 P2093 Q34649050-9E46CBB5-E026-4EE4-BBF5-E78673D0D5E4 @default.
- Q34649050 P2093 Q34649050-A327C880-61F6-47F3-B502-86A66A5E773D @default.
- Q34649050 P2093 Q34649050-B1A2FEA4-D882-497B-9406-69CF1AC987C3 @default.
- Q34649050 P2093 Q34649050-EA6FE6FE-650D-4160-ADFC-3223A3D5AD51 @default.
- Q34649050 P2093 Q34649050-EC5A2C08-BC4D-4FB3-BBB5-EC7227A7D275 @default.
- Q34649050 P2860 Q34649050-03299527-A5F4-4AA4-8CF2-7BAD45C131A2 @default.
- Q34649050 P2860 Q34649050-03832324-9525-4037-A947-D60FC1A01F8F @default.
- Q34649050 P2860 Q34649050-03856D2D-AB39-4C1F-B340-66E12CD70CB3 @default.
- Q34649050 P2860 Q34649050-06EE988C-90B2-44F7-A25A-8C979D83667A @default.
- Q34649050 P2860 Q34649050-0E039F18-9795-4215-A193-2BA8BE611D7B @default.
- Q34649050 P2860 Q34649050-12219066-2907-42FB-B6FA-AA5EA1550BEA @default.
- Q34649050 P2860 Q34649050-1449399F-EC96-4F87-8BC3-EB119F0C95F6 @default.
- Q34649050 P2860 Q34649050-17784712-73C4-459A-9D79-92CCA64C1446 @default.
- Q34649050 P2860 Q34649050-17AC1327-C60B-45E4-9C4A-B257D386F1D1 @default.
- Q34649050 P2860 Q34649050-223768FC-0611-4AF3-8B9C-09076637BC00 @default.
- Q34649050 P2860 Q34649050-2B02C29E-A0C9-4860-880A-4D966EB0CE32 @default.
- Q34649050 P2860 Q34649050-3370E1E6-13C3-4325-90A7-BE742F5BBF50 @default.
- Q34649050 P2860 Q34649050-3E83551E-353D-48F3-885A-0AB895580376 @default.
- Q34649050 P2860 Q34649050-40B9EAE9-7989-43F1-9562-06C8976051CE @default.
- Q34649050 P2860 Q34649050-4EAEA52F-6199-4FB7-8388-D3FC6EA3624F @default.